Source: Eur Respir J 2015; 45: 171-180



Rating:

Share or cite this content

Citations should be made in the following way:
Taveira-DaSilva Angelo M., Jones Amanda M., Julien-Williams Patricia, Yao Jianhua, Stylianou Mario, Moss Joel. Severity and outcome of cystic lung disease in women with tuberous sclerosis complex. Eur Respir J 2015; 45: 171-180

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary function tests for lymphangioleiomyomatosis screening in women with tuberous sclerosis complex Source: International Congress 2016 – Orphan diseases I Year: 2016 Alk-rearranged adenocarcinoma arising in lung lymphangioleiomyomatosis of a patient with tuberous sclerosis complex Source: International Congress 2019 – Lung cancer? Year: 2019 Natural history of incidental sporadic or tuberous sclerosis complex associated lymphangioleiomyomatosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Rate of FEV1 decline in lymphangioleiomyomatosis associated with tuberous sclerosis complex Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Hemoptysis: rare pulmonary manifestation of tuberous sclerosis in childhood Source: Eur Respir J 2006; 28: Suppl. 50, 544s Year: 2006 Lymphangioleiomyomatosis Source: Eur Respir J 2006; 27: 1056-1065 Year: 2006 Disease course and outcome of progressive interstitial lung disease in systemic sclerosis Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019 Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis Source: Eur Respir J 2008; 31: 678-680 Year: 2008 Predictors of progression in systemic sclerosis patients with interstitial lung disease Source: Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019 Year: 2020 Three cases of idiopathic pleuroparenchymal fibroelastosis associated with amyotrophic lateral sclerosis Source: International Congress 2014 – ILDs 4 Year: 2014 Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation Source: ERJ Open Res, 4 (2) 00159-2017; 10.1183/23120541.00159-2017 Year: 2018 Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 The prognostic role of OSA at the onset of amyotrophic lateral sclerosis Source: Annual Congress 2013 –Long-term NIV: children, neuromuscular patients and technical aspects Year: 2013 Amyotrophic lateral sclerosis: predictors of respiratory impairment at disease diagnosis Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions Year: 2019 Clinical characteristics of interstitial lung fibrosis in progressive systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 95s Year: 2006 Tuberous sclerosis complex (TSC) with pulmonary involvement - a retrospective review of 4 cases Source: Eur Respir J 2002; 20: Suppl. 38, 448s Year: 2002 Predictive factors of survival in amyotrophic lateral sclerosis patients with respiratory dysfunction Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation Year: 2012 Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Multiple cystic lung disease Source: Eur Respir Rev 2015; 24: 552-564 Year: 2015